On October 5th, in Barcelona, Spain, right after hashtag#EANM2025 scientific program concluded, we hosted an event built around the users of BIOEMTECH technology and the data it produces.
Barcelona gave us the perfect frame, and our users gave us the perfect focus.
We started with our CVO George Loudos giving a glimpse behind the eyes™, a reflection on the philosophy behind our imaging systems, and the fine balance between what we’ve achieved and what’s still to come.
From there, we moved into the world of theranostics with Jacob Hestermann, CSO of Ratio Therapeutics, who brought ²²⁵Ac 𝑖𝑛 𝑣𝑖𝑣𝑜 imaging into focus, showing how the γ-eye™ enables to capture the dynamics of RadioLigand Therapy in real time.
Finally, Antonio Shegani, Research associate @ NCSR “DEMOKRITOS” & CEO of NuclearPharm, showed how high-resolution 𝑖𝑛 𝑣𝑖𝑣𝑜 PET tomography with the β-eye™ can reveal the fine details of molecular processes.
By letting them see through our eyes™ systems, we embrace our users to translate ideas into outcomes.